Cara Therapeutics | CARA - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Acadia Pharmaceuticals USD 160.79M 14.06M 2026-03
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Cara Therapeutics USD 2.19M 2.45M 2025-09
Cassava Sciences USD 3.89M 2.77M 2026-03
Chugai Pharma JPY 28.9B 8.02B 2026-03
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.43M 222K 2026-03
CSL USD 1.23B 498M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Halozyme Therapeutics USD 46.29M 18.35M 2026-03
J&J USD 6.03B 719M 2026-03
Neurocrine Biosciences USD 318.5M 16.7M 2026-03
Pacira USD 83.88M 7.99M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
RedHill Biopharma USD 4.48M 1.52M 2024-03
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12